Osaic Holdings’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Osaic Holdings’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$33	Hold	25	–	–	﹤0.01%	7976
2026 Q2	$44	Hold	25	–	–	﹤0.01%	7880
2026 Q1	$43	Hold	25	–	–	﹤0.01%	7688
2025 Q4	$51	Hold	25	–	–	﹤0.01%	7694
2025 Q3	$141	Hold	25	–	–	﹤0.01%	7728
2025 Q2	$237	Hold	25	–	–	﹤0.01%	7477
2025 Q1	$184	Hold	25	–	–	﹤0.01%	7177
2024 Q4	$645	Buy	+25	New	+$552	﹤0.01%	6951

Other funds holding SXTP

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Osaic Holdings's SXTP Position: Q3 2026 in Review

Osaic Holdings held its 60 Degrees Pharmaceuticals (SXTP) position steady in Q3 2026 at 25 shares worth $33. The position accounts for ﹤0.01% of the portfolio, ranked #7976.

Osaic Holdings first reported a position in SXTP in Q4 2024 and has held it in 8 quarters since. The position peaked at $645 in Q4 2024. 5 funds tracked by Wall St. Rank hold SXTP as of Q3 2026.

Osaic Holdings held 25 shares of 60 Degrees Pharmaceuticals worth $33 as of Q3 2026.
Osaic Holdings left its 60 Degrees Pharmaceuticals share count unchanged in Q3 2026.
60 Degrees Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7976 holding.
Osaic Holdings first reported a position in 60 Degrees Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
Osaic Holdings's 60 Degrees Pharmaceuticals position peaked at $645 in Q4 2024.
5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.